Rankings
▼
Calendar
CRIS
Curis, Inc.
$15M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+24.1% YoY
Gross Profit
$3M
99.5% margin
Operating Income
-$9M
-268.9% margin
Net Income
-$10M
-287.5% margin
EPS (Diluted)
$-1.25
QoQ Revenue Growth
+14.1%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$41M
Total Liabilities
$47M
Stockholders' Equity
-$6M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$3M
+24.1%
Gross Profit
$3M
$3M
+26.0%
Operating Income
-$9M
-$12M
+26.3%
Net Income
-$10M
-$12M
+17.9%
← FY 2024
All Quarters
Q1 2025 →
CRIS Q4 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena